Washington Trust Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-364
| Closed | -$1.89K | – | 692 |
|
|
2024
Q3 | $1.89K | Hold |
364
| – | – | ﹤0.01% | 638 |
|
|
2024
Q2 | $936 | Hold |
364
| – | – | ﹤0.01% | 652 |
|
|
2024
Q1 | $1.79K | Hold |
364
| – | – | ﹤0.01% | 640 |
|
|
2023
Q4 | $3.2K | Buy |
364
+120
| +49% | +$1.06K | ﹤0.01% | 620 |
|
|
2023
Q3 | $2.8K | Hold |
244
| – | – | ﹤0.01% | 615 |
|
|
2023
Q2 | $6.18K | Hold |
244
| – | – | ﹤0.01% | 519 |
|
|
2023
Q1 | $7.86K | Buy |
244
+47
| +24% | +$1.51K | ﹤0.01% | 537 |
|
|
2022
Q4 | $3.64K | Hold |
197
| – | – | ﹤0.01% | 652 |
|
|
2022
Q3 | $5K | Hold |
197
| – | – | ﹤0.01% | 732 |
|
|
2022
Q2 | $3K | Hold |
197
| – | – | ﹤0.01% | 853 |
|
|
2022
Q1 | $4K | Hold |
197
| – | – | ﹤0.01% | 876 |
|
|
2021
Q4 | $3K | Buy |
+197
| New | +$3K | ﹤0.01% | 947 |
|